BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic hepatitis C
1
Letter to the Editor: Steatotic liver disease in chronic hepatitis C - a marker of systemic risk, not direct-acting antiviral treatment failure
6/26/2026 9:50:22 AM | Browse: 42 | Download: 127
2
Genetic polymorphism of IFI16 and AIM2 among Pakistani hepatitis C virus-induced fibrosis patients
5/26/2026 3:52:10 AM | Browse: 20 | Download: 200
3
Baseline and longitudinal biomarkers predict hepatocellular carcinoma in chronic hepatitis C: A cohort study
5/14/2026 9:17:09 AM | Browse: 39 | Download: 165
4
Non-invasive prediction of significant hepatic fibrosis in individuals with chronic hepatitis C infection using fibrosis risk score and machine learning models
3/26/2026 9:22:59 AM | Browse: 48 | Download: 180
5
Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals
10/27/2025 10:57:49 AM | Browse: 394 | Download: 588
6
Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
9/25/2025 11:24:03 AM | Browse: 194 | Download: 546
7
Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease
8/27/2025 9:21:09 AM | Browse: 354 | Download: 597
8
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs
6/26/2025 7:27:55 AM | Browse: 324 | Download: 865
9
Transient elastography and diffusion-weighted magnetic resonance imaging for assessment of liver fibrosis in children with chronic hepatitis C
8/29/2024 7:51:41 AM | Browse: 299 | Download: 1033
10
Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
3/27/2024 1:28:19 PM | Browse: 254 | Download: 961
11
Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999-2019)
3/11/2024 2:44:49 PM | Browse: 392 | Download: 1372
12
Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study
2/4/2024 10:57:42 AM | Browse: 511 | Download: 1673
13
Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
11/24/2023 6:10:12 AM | Browse: 495 | Download: 1569
14
Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
11/24/2023 6:10:11 AM | Browse: 578 | Download: 1323
15
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
10/25/2023 8:49:11 AM | Browse: 417 | Download: 1353
16
Sarcopenia in chronic viral hepatitis: From concept to clinical relevance
5/24/2023 9:31:05 AM | Browse: 552 | Download: 1307
17
Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C
2/10/2023 9:15:29 AM | Browse: 602 | Download: 1297
18
Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients
6/9/2022 7:17:55 AM | Browse: 803 | Download: 2615
19
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
1/21/2022 8:16:14 AM | Browse: 771 | Download: 2034
20
Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study
11/10/2021 7:13:09 AM | Browse: 1085 | Download: 1838
21
Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
5/14/2021 10:27:31 AM | Browse: 991 | Download: 2098
22
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study
5/10/2021 7:46:10 AM | Browse: 811 | Download: 2165
23
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
4/29/2021 2:12:02 AM | Browse: 891 | Download: 1871
24
Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients
2/25/2021 3:45:30 PM | Browse: 1241 | Download: 2908
25
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 1184 | Download: 2081
26
Liver-related effects of chronic hepatitis C antiviral treatment
6/14/2020 1:45:26 PM | Browse: 1301 | Download: 2421
27
Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus
4/23/2020 10:34:55 AM | Browse: 941 | Download: 2720
28
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 1550 | Download: 2356
29
Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy
8/26/2019 2:56:47 AM | Browse: 1211 | Download: 3369
30
High prevalence of occult hepatitis C infection in predialysis patients
1/27/2019 7:04:05 AM | Browse: 1112 | Download: 2570
31
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM | Browse: 1004 | Download: 1837
32
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
3/26/2018 8:48:04 AM | Browse: 1661 | Download: 3840
33
Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis
1/26/2018 8:09:36 AM | Browse: 1484 | Download: 2484
34
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 1596 | Download: 3069
35
Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment
7/7/2017 11:41:16 AM | Browse: 1396 | Download: 3002
36
Interferon related pericarditis: Review
6/26/2017 12:49:43 AM | Browse: 1411 | Download: 2007
37
Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
6/14/2017 9:25:57 AM | Browse: 1392 | Download: 3028
38
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 2319 | Download: 4477
39
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM | Browse: 1711 | Download: 3087
40
Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
4/6/2017 6:30:00 PM | Browse: 1630 | Download: 2589
41
Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C
2/27/2017 8:50:00 AM | Browse: 1543 | Download: 2578
42
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
2/17/2017 8:32:00 AM | Browse: 1444 | Download: 2367
43
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
11/26/2016 6:56:00 PM | Browse: 1569 | Download: 3348
44
Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature
11/6/2016 3:43:00 PM | Browse: 1187 | Download: 2060
45
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
10/14/2016 1:37:00 PM | Browse: 1561 | Download: 2209
46
Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
9/30/2016 5:59:00 PM | Browse: 1549 | Download: 3161
47
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
9/4/2016 2:49:00 PM | Browse: 1734 | Download: 2724
48
Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles
7/29/2016 8:32:00 PM | Browse: 1523 | Download: 2615
49
Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
4/19/2016 9:45:00 AM | Browse: 1617 | Download: 3582
50
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
3/23/2016 4:26:00 PM | Browse: 1773 | Download: 3078
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.